ZENLABS ETHICA | A-1 ACID | ZENLABS ETHICA/ A-1 ACID |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -243.7 | 236.2 | - | View Chart |
P/BV | x | 3.1 | 8.6 | 35.8% | View Chart |
Dividend Yield | % | 0.5 | 0.4 | 131.6% |
ZENLABS ETHICA A-1 ACID |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ZENLABS ETHICA Mar-23 |
A-1 ACID Mar-23 |
ZENLABS ETHICA/ A-1 ACID |
5-Yr Chart Click to enlarge
|
||
High | Rs | 83 | 390 | 21.3% | |
Low | Rs | 27 | 246 | 11.0% | |
Sales per share (Unadj.) | Rs | 102.7 | 287.5 | 35.7% | |
Earnings per share (Unadj.) | Rs | 0.8 | 3.2 | 23.5% | |
Cash flow per share (Unadj.) | Rs | 2.7 | 6.7 | 40.0% | |
Dividends per share (Unadj.) | Rs | 0.25 | 1.50 | 16.7% | |
Avg Dividend yield | % | 0.5 | 0.5 | 96.4% | |
Book value per share (Unadj.) | Rs | 14.9 | 42.1 | 35.4% | |
Shares outstanding (eoy) | m | 6.51 | 11.50 | 56.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.5 | 1.1 | 48.4% | |
Avg P/E ratio | x | 73.2 | 99.5 | 73.5% | |
P/CF ratio (eoy) | x | 20.6 | 47.6 | 43.2% | |
Price / Book Value ratio | x | 3.7 | 7.6 | 48.8% | |
Dividend payout | % | 33.3 | 47.0 | 70.9% | |
Avg Mkt Cap | Rs m | 358 | 3,656 | 9.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 43 | 13 | 339.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 669 | 3,306 | 20.2% | |
Other income | Rs m | 1 | 64 | 2.0% | |
Total revenues | Rs m | 670 | 3,369 | 19.9% | |
Gross profit | Rs m | 23 | 43 | 54.1% | |
Depreciation | Rs m | 12 | 40 | 31.2% | |
Interest | Rs m | 5 | 18 | 29.1% | |
Profit before tax | Rs m | 7 | 48 | 14.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 12 | 16.1% | |
Profit after tax | Rs m | 5 | 37 | 13.3% | |
Gross profit margin | % | 3.5 | 1.3 | 267.2% | |
Effective tax rate | % | 27.4 | 23.8 | 115.1% | |
Net profit margin | % | 0.7 | 1.1 | 65.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 375 | 458 | 81.9% | |
Current liabilities | Rs m | 295 | 143 | 205.8% | |
Net working cap to sales | % | 12.0 | 9.5 | 126.5% | |
Current ratio | x | 1.3 | 3.2 | 39.8% | |
Inventory Days | Days | 4 | 8 | 51.0% | |
Debtors Days | Days | 1,184 | 421 | 281.0% | |
Net fixed assets | Rs m | 58 | 236 | 24.4% | |
Share capital | Rs m | 65 | 115 | 56.6% | |
"Free" reserves | Rs m | 32 | 369 | 8.7% | |
Net worth | Rs m | 97 | 484 | 20.0% | |
Long term debt | Rs m | 11 | 47 | 23.7% | |
Total assets | Rs m | 433 | 694 | 62.4% | |
Interest coverage | x | 2.3 | 3.6 | 62.4% | |
Debt to equity ratio | x | 0.1 | 0.1 | 118.4% | |
Sales to assets ratio | x | 1.5 | 4.8 | 32.4% | |
Return on assets | % | 2.4 | 7.9 | 29.8% | |
Return on equity | % | 5.0 | 7.6 | 66.5% | |
Return on capital | % | 11.2 | 12.5 | 89.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 15 | 187 | 8.1% | |
From Investments | Rs m | -15 | -35 | 41.7% | |
From Financial Activity | Rs m | 1 | -153 | -0.4% | |
Net Cashflow | Rs m | 1 | 0 | -311.1% |
Indian Promoters | % | 53.0 | 70.0 | 75.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 2.9 | - | |
FIIs | % | 0.0 | 2.9 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 47.0 | 30.0 | 156.9% | |
Shareholders | 2,482 | 2,028 | 122.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ZENLABS ETHICA With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | NEELKANTH TECH. | A-1 ACID | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.11% | 1.22% | 0.26% |
1-Month | 9.26% | 3.78% | 0.17% |
1-Year | -13.94% | 1.29% | 54.18% |
3-Year CAGR | 23.75% | 56.59% | 15.01% |
5-Year CAGR | -3.26% | 47.20% | 19.85% |
* Compound Annual Growth Rate
Here are more details on the NEELKANTH TECH. share price and the A-1 ACID share price.
Moving on to shareholding structures...
The promoters of NEELKANTH TECH. hold a 53.0% stake in the company. In case of A-1 ACID the stake stands at 70.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NEELKANTH TECH. and the shareholding pattern of A-1 ACID.
Finally, a word on dividends...
In the most recent financial year, NEELKANTH TECH. paid a dividend of Rs 0.3 per share. This amounted to a Dividend Payout ratio of 33.3%.
A-1 ACID paid Rs 1.5, and its dividend payout ratio stood at 47.0%.
You may visit here to review the dividend history of NEELKANTH TECH., and the dividend history of A-1 ACID.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.